MovDisordV3, PubMed, Curation, bibRecord, 000394

Dopaminergic agents and nutritional status in Parkinson's disease.

Identifieur interne : 000394 ( PubMed/Curation ); précédent : 000393; suivant : 000395

Dopaminergic agents and nutritional status in Parkinson's disease.

Auteurs : Alice Laudisio [Italie] ; Davide L. Vetrano ; Eleonora Meloni ; Diego Ricciardi ; Francesco Franceschi ; Anna Rita Bentivoglio ; Roberto Bernabei ; Giuseppe Zuccalà

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2014.

RBID : pubmed:25214286

English descriptors

KwdEn :
- Aged, Aged, 80 and over, Dopamine Agents (adverse effects), Female, Humans, Levodopa (adverse effects), Levodopa (therapeutic use), Male, Malnutrition (chemically induced), Middle Aged, Nutritional Status (drug effects), Nutritional Status (physiology), Parkinson Disease (drug therapy).
MESH :
- chemical , adverse effects : Dopamine Agents, Levodopa.
- chemical , therapeutic use : Levodopa.
- chemically induced : Malnutrition.
- drug effects : Nutritional Status.
- drug therapy : Parkinson Disease.
- physiology : Nutritional Status.
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged.

Abstract

Malnutrition has been found in up to 24% of patients with Parkinson's disease; dopaminergic drugs might impair nutritional status. We evaluated the association of nutritional status with the use of dopaminergic agents.

DOI: 10.1002/mds.25991
PubMed: 25214286

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000394

Links to Exploration step

pubmed:25214286

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopaminergic agents and nutritional status in Parkinson's disease.</title>
<author><name sortKey="Laudisio, Alice" sort="Laudisio, Alice" uniqKey="Laudisio A" first="Alice" last="Laudisio">Alice Laudisio</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Geriatrics, Campus Bio-Medico University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Geriatrics, Campus Bio-Medico University, Rome</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vetrano, Davide L" sort="Vetrano, Davide L" uniqKey="Vetrano D" first="Davide L" last="Vetrano">Davide L. Vetrano</name>
</author>
<author><name sortKey="Meloni, Eleonora" sort="Meloni, Eleonora" uniqKey="Meloni E" first="Eleonora" last="Meloni">Eleonora Meloni</name>
</author>
<author><name sortKey="Ricciardi, Diego" sort="Ricciardi, Diego" uniqKey="Ricciardi D" first="Diego" last="Ricciardi">Diego Ricciardi</name>
</author>
<author><name sortKey="Franceschi, Francesco" sort="Franceschi, Francesco" uniqKey="Franceschi F" first="Francesco" last="Franceschi">Francesco Franceschi</name>
</author>
<author><name sortKey="Bentivoglio, Anna Rita" sort="Bentivoglio, Anna Rita" uniqKey="Bentivoglio A" first="Anna Rita" last="Bentivoglio">Anna Rita Bentivoglio</name>
</author>
<author><name sortKey="Bernabei, Roberto" sort="Bernabei, Roberto" uniqKey="Bernabei R" first="Roberto" last="Bernabei">Roberto Bernabei</name>
</author>
<author><name sortKey="Zuccala, Giuseppe" sort="Zuccala, Giuseppe" uniqKey="Zuccala G" first="Giuseppe" last="Zuccalà">Giuseppe Zuccalà</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25214286</idno>
<idno type="pmid">25214286</idno>
<idno type="doi">10.1002/mds.25991</idno>
<idno type="wicri:Area/PubMed/Corpus">000394</idno>
<idno type="wicri:Area/PubMed/Curation">000394</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Dopaminergic agents and nutritional status in Parkinson's disease.</title>
<author><name sortKey="Laudisio, Alice" sort="Laudisio, Alice" uniqKey="Laudisio A" first="Alice" last="Laudisio">Alice Laudisio</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Geriatrics, Campus Bio-Medico University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Geriatrics, Campus Bio-Medico University, Rome</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vetrano, Davide L" sort="Vetrano, Davide L" uniqKey="Vetrano D" first="Davide L" last="Vetrano">Davide L. Vetrano</name>
</author>
<author><name sortKey="Meloni, Eleonora" sort="Meloni, Eleonora" uniqKey="Meloni E" first="Eleonora" last="Meloni">Eleonora Meloni</name>
</author>
<author><name sortKey="Ricciardi, Diego" sort="Ricciardi, Diego" uniqKey="Ricciardi D" first="Diego" last="Ricciardi">Diego Ricciardi</name>
</author>
<author><name sortKey="Franceschi, Francesco" sort="Franceschi, Francesco" uniqKey="Franceschi F" first="Francesco" last="Franceschi">Francesco Franceschi</name>
</author>
<author><name sortKey="Bentivoglio, Anna Rita" sort="Bentivoglio, Anna Rita" uniqKey="Bentivoglio A" first="Anna Rita" last="Bentivoglio">Anna Rita Bentivoglio</name>
</author>
<author><name sortKey="Bernabei, Roberto" sort="Bernabei, Roberto" uniqKey="Bernabei R" first="Roberto" last="Bernabei">Roberto Bernabei</name>
</author>
<author><name sortKey="Zuccala, Giuseppe" sort="Zuccala, Giuseppe" uniqKey="Zuccala G" first="Giuseppe" last="Zuccalà">Giuseppe Zuccalà</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Dopamine Agents (adverse effects)</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Malnutrition (chemically induced)</term>
<term>Middle Aged</term>
<term>Nutritional Status (drug effects)</term>
<term>Nutritional Status (physiology)</term>
<term>Parkinson Disease (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Malnutrition</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Nutritional Status</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Nutritional Status</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Malnutrition has been found in up to 24% of patients with Parkinson's disease; dopaminergic drugs might impair nutritional status. We evaluated the association of nutritional status with the use of dopaminergic agents.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">25214286</PMID>
<DateCreated><Year>2014</Year>
<Month>10</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>06</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>29</Volume>
<Issue>12</Issue>
<PubDate><Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Dopaminergic agents and nutritional status in Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>1543-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.25991</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Malnutrition has been found in up to 24% of patients with Parkinson's disease; dopaminergic drugs might impair nutritional status. We evaluated the association of nutritional status with the use of dopaminergic agents.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed data from 75 elderly patients with Parkinson's disease attending a geriatric day hospital. Nutritional status was assessed by the Mini Nutritional Assessment (MNA). Dopaminergic drugs were normalized for weight.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In linear regression, total levodopa (l-dopa) equivalent daily dose (LEDD) was associated with worse MNA (B = -0.14, 95% CI = -0.26--0.02; P = 0.019). This association remained significant only for l-dopa (B = -0.19, 95% CI = -0.32--0.52; P = 0.007), but not dopaminergic agent dosages. Increasing l-dopa dosages were associated with increasing probability of risk of malnutrition (P for trend = 0.049).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In our population, LEDD was associated with worse nutritional status and risk of malnutrition; this association was limited to use of l-dopa.</AbstractText>
<CopyrightInformation>© 2014 International Parkinson and Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laudisio</LastName>
<ForeName>Alice</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Geriatrics, Campus Bio-Medico University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vetrano</LastName>
<ForeName>Davide L</ForeName>
<Initials>DL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Meloni</LastName>
<ForeName>Eleonora</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ricciardi</LastName>
<ForeName>Diego</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Franceschi</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bentivoglio</LastName>
<ForeName>Anna Rita</ForeName>
<Initials>AR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bernabei</LastName>
<ForeName>Roberto</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zuccalà</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015259">Dopamine Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D044342">Malnutrition</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009752">Nutritional Status</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Parkinson's disease</Keyword>
<Keyword MajorTopicYN="N">dopaminergic drugs</Keyword>
<Keyword MajorTopicYN="N">epidemiology</Keyword>
<Keyword MajorTopicYN="N">levodopa</Keyword>
<Keyword MajorTopicYN="N">nutritional status</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>9</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>7</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>7</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2014</Year>
<Month>9</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>9</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>9</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>6</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25214286</ArticleId>
<ArticleId IdType="doi">10.1002/mds.25991</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000394 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000394 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:25214286
   |texte=   Dopaminergic agents and nutritional status in Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:25214286" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Dopaminergic agents and nutritional status in Parkinson's disease.

Dopaminergic agents and nutritional status in Parkinson's disease.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki